BackCOM_SIMPLECALENDAR_PRINTSend e-mailvCal/iCal
Fechas:
17.08 - 19.08.2020  STATUS
Lugar:
Virtual - on line
Website:
https://virtual.keystonesymposia...

Cancer immunotherapy provides unprecedented long-term antitumor activity in some patients, however the majority of patients with advanced cancers only experience short-term remission. To achieve better outcomes for everyone will require a mechanistic understanding of response, and resistance, to these therapies, including immune inhibitory checkpoint blockade and T-cell engineering. These insights will provide rationale for how to best combine these therapeutic approaches for sustained clinical success.

Read more

Socios Protectores